Skip to main content
Equibles

Kovack Advisors, Inc.

Position in ABEO — Abeona Therapeutics Inc.

CIK 1728321 FT. LAUDERDALE, FL
Back to ABEO Full portfolio

Position in ABEO

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$65,260
+$17,952 QoQ
Shares Held
10,560
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#88
of 125 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABEO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Kovack Advisors, Inc. holds $5,014,818 across 13 Biotechnology names. ABEO ranks #11 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZVRA
Zevra Therapeutics, Inc.
 171,151 $2,454,305
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,315 $653,199
3 MRNA
Moderna, Inc.
 3,995 $279,769
4 BBIO
BridgeBio Pharma, Inc.
 3,675 $273,714
5 CRSP
CRISPR Therapeutics AG
 4,936 $269,209
6 REGN
Regeneron Pharmaceuticals, Inc.
 392 $244,427
7 JAZZ
Jazz Pharmaceuticals plc
 921 $221,933
8 IBRX
ImmunityBio, Inc.
 20,808 $182,174

All Filings in ABEO

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $65,260 10,560
2026-03-31 $47,308 10,560